88
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy

, , , , , , & show all
Pages 1061-1070 | Published online: 07 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Danial Mohabati, Elon HC van Dijk, Thomas J van Rijssen, Eiko K de Jong, Myrte B Breukink, Jose P Martinez-Ciriano, Greet Dijkman, Carel B Hoyng, Sascha Fauser, Suzanne Yzer & Camiel JF Boon. (2018) Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy. Clinical Ophthalmology 12, pages 2167-2176.
Read now

Articles from other publishers (33)

Alex M. Lynch, Laura K. Ruterbories, James B. Robertson, Katharine F. Lunn & Freya M. Mowat. (2023) Hemostatic profiles in dogs with sudden acquired retinal degeneration syndrome. Journal of Veterinary Internal Medicine.
Crossref
Adrian T. Fung, Yi Yang & Andrew W. Kam. (2023) Central serous chorioretinopathy: A review. Clinical & Experimental Ophthalmology 51:3, pages 243-270.
Crossref
Helena M. A. Feenstra, Elon H. C. van Dijk, Thomas J. van Rijssen, Roula Tsonaka, Roselie M. H. Diederen, Carel B. Hoyng, Reinier O. Schlingemann & Camiel J. F. Boon. (2022) Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3. Graefe's Archive for Clinical and Experimental Ophthalmology 261:3, pages 659-668.
Crossref
Fang Zheng, Jingliang He, Zhitao Su, Ye Liu, Yufeng Xu, Lei Liu & Panpan Ye. (2022) OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy. BMC Ophthalmology 22:1.
Crossref
Tae Keun Yoo, Seo Hee Kim, Min Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Jinyoung Yeo & Eun Young Choi. (2022) DeepPDT-Net: predicting the outcome of photodynamic therapy for chronic central serous chorioretinopathy using two-stage multimodal transfer learning. Scientific Reports 12:1.
Crossref
Helena M.A. Feenstra, Elon H.C. van Dijk, Thomas J. van Rijssen, Roula Tsonaka, Roselie M.H. Diederen, Reinier O. Schlingemann, Carel B. Hoyng & Camiel J.F. Boon. (2022) Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients. Ophthalmology Retina 6:10, pages 930-938.
Crossref
Supriya Arora, Dmitrii S. Maltsev, Sumit Singh Randhir, Niroj Kumar Sahoo, Mahima Jhingan, Deepika Parmeshwarappa, Tarun Arora, Alexei Kulikov, Claudio Iovino, Dinah Zur, Gilad Fainberg, Mohammed Nasar Ibrahim, Filippo Tatti, Ramkailash Gujar, Ramesh Venkatesh, Nikitha Reddy, Ram Snehith, Enrico Peiretti, Marco Lupidi & Jay Chhablani. (2021) One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysis. European Journal of Ophthalmology 32:4, pages 2319-2327.
Crossref
C. Lange, B. Bertram & D. Pauleikhoff. (2022) Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathyStellungnahme von BVA, DOG und RG zur Chorioretinopathia centralis serosa (CCS). Die Ophthalmologie 119:S2, pages 108-122.
Crossref
Pushpinder Kanda, Arnav Gupta, Chloe Gottlieb, Rustum Karanjia, Stuart G. Coupland & Manpartap Singh Bal. (2021) Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment. Eye 36:5, pages 941-962.
Crossref
David Xu, Elisha Garg, Kook Lee, Yoichi Sakurada, Atchara Amphornphruet, Nopasak Phasukkijwatana, Sandra Liakopoulos, Scott Eugene Pautler, Allan E Kreiger, Suzanne Yzer, Won Ki Lee, SriniVas Sadda, K Bailey Freund & David Sarraf. (2022) Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome. British Journal of Ophthalmology 106:4, pages 576-581.
Crossref
Helena M. A. Feenstra, Leo C. Hahn, Thomas J. van Rijssen, Roula Tsonaka, Myrte B. Breukink, Jan. E. E. Keunen, Petrus J. H. Peters, Greet Dijkman, Eric H. Souied, Robert E. MacLaren, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Elon H. C. van Dijk & Camiel J. F. Boon. (2022) EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina 42:4, pages 721-729.
Crossref
Supriya Arora, Dmitrii S. Maltsev, Niroj Kumar Sahoo, Deepika C. Parameshwarappa, Claudio Iovino, Tarun Arora, Alexei N. Kulikov, Filippo Tatti, Ramesh Venkatesh, Nikitha Gurram Reddy, Ram Snehith Pulipaka, Sumit Randhir Singh, Enrico Peiretti & Jay Chhablani. (2021) Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy. Eye 36:3, pages 517-523.
Crossref
. (2022) Stellungnahme von BVA, DOG und RG zur Chorioretinopathia centralis serosa (CCS). Klinische Monatsblätter für Augenheilkunde 239:02, pages 217-232.
Crossref
Clemens Lange, B. Bertram & D. Pauleikhoff. (2021) Stellungnahme von BVA, DOG und RG zur Chorioretinopathia centralis serosa (CCS)Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy. Der Ophthalmologe 119:2, pages 148-162.
Crossref
Richard F. Spaide, Chui Ming Gemmy Cheung, Hidetaka Matsumoto, Shoji Kishi, Camiel J.F. Boon, Elon H.C. van Dijk, Martine Mauget-Faysse, Francine Behar-Cohen, M. Elizabeth Hartnett, Sobha Sivaprasad, Tomohiro Iida, David M. Brown, Jay Chhablani & Peter M. Maloca. (2022) Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders. Progress in Retinal and Eye Research 86, pages 100973.
Crossref
Maximilian Pfau, Elon H. C. van Dijk, Thomas J. van Rijssen, Steffen Schmitz-Valckenberg, Frank G. Holz, Monika Fleckenstein & Camiel J. F. Boon. (2021) Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence. Scientific Reports 11:1.
Crossref
Elon H.C. van Dijk & Camiel J.F. Boon. (2021) Serous business: Delineating the broad spectrum of diseases with subretinal fluid in the macula. Progress in Retinal and Eye Research 84, pages 100955.
Crossref
Stefano Da Pozzo, Pierluigi Iacono, Alessandro Arrigo & Maurizio Battaglia Parodi. (2021) The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy. Pharmaceuticals 14:2, pages 105.
Crossref
Manuel Vilela & Carolina Mengue. (2020) Central Serous Chorioretinopathy Classification. Pharmaceuticals 14:1, pages 26.
Crossref
Rebecca Kaye, Shruti Chandra, Jay Sheth, Camiel J.F. Boon, Sobha Sivaprasad & Andrew Lotery. (2020) Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities. Progress in Retinal and Eye Research 79, pages 100865.
Crossref
Danial Mohabati, Carel B. Hoyng, Suzanne Yzer & Camiel J. F. Boon. (2020) CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina 40:9, pages 1742-1750.
Crossref
Danial Mohabati, Rosa L. Schellevis, Elon H. C. van Dijk, Sascha Fauser, Anneke I. den Hollander, Carel B. Hoyng, Eiko K. De Jong, Suzanne Yzer & Camiel J. F. Boon. (2020) GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY. Retina 40:9, pages 1734-1741.
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Paula Scholz, Myrte B. Breukink, Greet Dijkman, Petrus J.H. Peters, Roula Tsonaka, Robert E. MacLaren, Susan M. Downes, Sascha Fauser, Camiel J.F. Boon & Carel B. Hoyng. (2020) Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial. American Journal of Ophthalmology 216, pages 80-89.
Crossref
Ahmed M. Hagag, Shruti Chandra, Hagar Khalid, Ali Lamin, Pearse A. Keane, Andrew J. Lotery & Sobha Sivaprasad. (2020) Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy. Journal of Clinical Medicine 9:6, pages 1934.
Crossref
Elon H. C. van Dijk, Thomas J. van Rijssen, Yousif Subhi & Camiel J. F. Boon. (2020) Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach. Ophthalmology and Therapy 9:2, pages 329-342.
Crossref
Andrew Walkden, Olivia Atkinson, Emma Linton, Adam Bull, Laina Abraham & Ramandeep Chhabra. (2020) Visual and anatomical outcomes of central serous chorioretinopathy patients presenting to a tertiary unit: a prospective analysis. Therapeutic Advances in Ophthalmology 12, pages 251584142092319.
Crossref
Danial Mohabati, Rosa L. Schellevis, Elon H. C. van Dijk, Lebriz Altay, Sascha Fauser, Carel B. Hoyng, Eiko K. De Jong, Camiel J. F. Boon & Suzanne Yzer. (2019) GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY. Retina 39:12, pages 2303-2310.
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Suzanne Yzer, Kyoko Ohno-Matsui, Jan E.E. Keunen, Reinier O. Schlingemann, Sobha Sivaprasad, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Felice Cardillo Piccolino, Jay K. Chhablani, Timothy Y.Y. Lai, Andrew J. Lotery, Michael Larsen, Frank G. Holz, K. Bailey Freund, Lawrence A. Yannuzzi & Camiel J.F. Boon. (2019) Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Progress in Retinal and Eye Research 73, pages 100770.
Crossref
Elodie Bousquet, Min Zhao, Alejandra Daruich & Francine Behar-Cohen. (2019) Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence. Experimental Eye Research 187, pages 107754.
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Paula Scholz, Myrte B. Breukink, Rocio Blanco-Garavito, Eric H. Souied, Jan E.E. Keunen, Robert E. MacLaren, Giuseppe Querques, Sascha Fauser, Susan M. Downes, Carel B. Hoyng & Camiel J.F. Boon. (2019) Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3. American Journal of Ophthalmology 205, pages 1-10.
Crossref
Thomas J. van Rijssen, Elon H. C. van Dijk, Paula Scholz, Myrte B. Breukink, Rocio Blanco-Garavito, Eric H. Souied, Robert E. MacLaren, Giuseppe Querques, Sascha Fauser, Carel B. Hoyng, Susan M. Downes & Camiel J. F. Boon. (2019) Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage. Graefe's Archive for Clinical and Experimental Ophthalmology 257:7, pages 1419-1425.
Crossref
Elon H.C. van Dijk, Sascha Fauser, Myrte B. Breukink, Rocio Blanco-Garavito, Jan E.E. Keunen, Joannes M.M. Groenewoud, Petrus J.H. Peters, Greet Dijkman, Eric H. Souied, Robert E. MacLaren, Giuseppe Querques, Susan M. Downes, Carel B. Hoyng & Camiel J.F. Boon. (2019) Reply. Ophthalmology 126:1, pages e11.
Crossref
Camiel J.F. Boon, Elon H.C. van Dijk & Suzanne Yzer. 2019. Central Serous Chorioretinopathy. Central Serous Chorioretinopathy 283 292 .